Philadelphia Inquirer (PA) 2000 Andrea Knox - Abstracts

Philadelphia Inquirer (PA) 2000 Andrea Knox
TitleSubjectAuthors
Activists target Campbell to protest bioengineered foods.(Groups calling for new regulations of modified crops rallied outside the soup maker's Camden headquarters.)Business, regionalAndrea Knox
A new chief executive in works for Campbell.(Camden, NJ-based Campbell Soup Co. appoints new chief executive officer)Business, regionalAndrea Knox
Centorcor drug stands to gain from a rival's success.Business, regionalAndrea Knox
Former Rhone-Poulenc Rorer chief will head ViroPharma; Michel de Rosen says the small Exton pharmaceutical firm is developing antiviral drugs that show promise.Business, regionalAndrea Knox
For West Chester biotech firm, market has been far from sleepy.Business, regionalAndrea Knox
Genuardi's goes against industry on food labeling.Business, regionalAndrea Knox
Hospital officials' selection draws ire.(Penn Health appointed the two top managers in Phoenixville without consulting the staff.)Business, regionalAndrea Knox
NovaCare unit's merger completed.Business, regionalAndrea Knox
Penn Health's CEO resigns.Business, regionalAndrea Knox
Penn system is recovering much faster than expected.(The hospital and health group has trimmed losses significantly and expects to be profitable this year.)Business, regionalAndrea Knox
Penn tries to end dissatisfaction of hospital's doctors.(University of Pennsylvania Health System appoints new executive director)Business, regionalAndrea Knox
Region gets $10.5 million for nanotechnology effort.(Pennsylvania Technology Investment Authority gives 3-year $10.5 mn for Nanotechnology Center)Business, regionalAndrea Knox
Researcher's wrong data sidetrack gene mapping project.Business, regionalAndrea Knox
Rival to buy local biotech pioneer Genovo; the Sharon Hill firm was the major corporate backer of gene therapy research at Penn. Those ties will end.Business, regionalAndrea Knox, Huntly Collins
Rohm and Haas issues new earnings warning.(Philadelphia, Penn.-based Rohm and Haas Co. issues profit warning about fourth-quarter earnings)Business, regionalAndrea Knox
Scientist's unorthodox style helped speed DNA research.Business, regionalAndrea Knox
SmithKline to acquire dental-care company.(Block Drug makes Sensodyne and Polident.)Business, regionalAndrea Knox
SmithKline to test a wound-healing drug.(The company is working with Human Genome Sciences to develop repifermin, a gene-based ulceration treatment.)Business, regionalAndrea Knox
Virtua, duPont hospitals link care.Business, regionalAndrea Knox
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.